Infarctsize™ is a trademark of Pharmahungary.

Pharmahungary is a technology leader CRO in the measurement of infarct size in different preclinical models of myocardial infarction. Infarct size is a gold standard end-point of preclinical and clinical studies of cardioprotection aginst myocardial ischemia and reperfusion injury.

News, 2010 Nov: Pharmahungary concluded the development of an upgraded version of its proprietary "infarctsize" system to measure the extent of myocardial infarction in preclinical models. The system consists of a high-thoughput, precision slicing hardware as well as an image analyzer & documentation software designed for the special needs for fast and reproducible measurement and documentation of infarct size.